Global Diabetic Neuropathy Market 2014-2018

Price :
Published : May-2014
No. of Pages : 55

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical, Therapeutics
Publisher : Technavio
More Reports
Title Price Buy Now

Takeda Pharmaceuticals USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company's products include pioglitazone and glimepiride, lubiprostone, pioglitazone, pioglitazone and metformin HCl, azilsartan medoxomil, alogliptin, peginesatide, lansoprazole, colchicine, USP, dexlansoprazole, ramelteon and febuxostat. It offers products in therapeutic areas including cardiovascular disease, central nervous system disorders, bone and joint disorders, gastroenterology, gynecology disorders, kidney disorders and other infectious diseases. TPUSA conducts research and development activities to develop new drugs. The company markets its products throug......

EnGeneIC Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference molecules, chemotherapeutic agents, and molecularly targeted drugs into targeted tumor cells. EnGeneIC's technologies include targeted drug delivery, EnGeneIC dream vector technology, targeted small interfering RNA delivery and targeted microRNA delivery. The company offers preclinical development and clinical trial services. It develops proprietary EDV nanocell platform for the delivery of chemotherapeutics and functional nucleic acids in cancer. The company operates in Lane Cove West, Austra......

Fate Therapeutics Inc (FATE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company's pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidates. Its immuno-oncology product candidates include adaptive NK, pluripotent cell-derived cancer immunotherapies, and engineered CAR and TCR T- cell immunotherapies. Its products are derived from pluripotent cells. Fate Therapeutics uses ex vivo cell programming approach to include cell-surface proteins, rapid and supra-physiologic activation or inhibition of therapeutically-relevant genes, and to regulate the therapeutic function. The company's immuno-regulatory cellular therapies promote immu......

NanoString Technologies Inc (NSTG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways among others. NanoString's nCounter analysis system provides cost-effective method to profile hundreds of miRNA, miRGE or DNA molecules simultaneously employing digital molecular barcoding technology. The company sells its products through direct sales force and distributors in the US, Europe, the Middle East and Asia-Pacific. NanoString is headquartered in Seattle, Wa......

Ferndale Pharma Group Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Ferndale Pharma Group Inc (Ferndale Pharma), formerly Ferndale Laboratories Inc is a manufacturer and distributor of pharmaceutical products. The company provides surgical instruments, medical supplies, skin care products, topical therapeutic products, prescription, over the counter products, and equipment to the medical profession. It offers contract manufacturing services such as pharmaceutical production, quality assurance, quality control, product development, warehousing, and distribution services. Ferndale Pharma serves to hospitals, healthcare practitioners, and patients. The company supplies skin care and topical therapeutic products for hospitals, pharmacies, and aesthetic professionals and their client. It operates in the US, and the UK. Ferndale Pharma is headquartere......

Genedata AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Bas......

Histogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen's proprietary technologies are used in various applications which include hair regrowth and skincare; therapeutics including orthopedics and oncology. The company's products are stabilized and bioactive in a biocompatible liquid formula. Its products are used as research tools for stem cell growth and therapeutics. It offers products to biotechnology companies and medical research institutes. Histogen is headquartered in San Diego, California, the US. Histogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile pr......

Innovate Biopharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Innovate Biopharmaceuticals Inc (Innovate) is a clinical stage biotechnology company that develops novel medicines for gastroenterological and orphan disorders. The company's pipeline product includes INN-329 in phase III for magnetic resonance cholangiopancreatography; and INN-108 in phase II for inflammatory bowel disorders, mild to moderate ulcerative colitis. Its MRCP is a clinical imaging method developed for the visualization of pancreatic ducts, and its secretin stimulated MRCP is a non-invasive, ionizing, radiation-free assessment of the pancreaticobiliary system. The company has patents across the US, Japan and other countries. Innovate is headquartered in Raleigh, North Carolina, the US. Innovate Biopharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alli......

MGB Biopharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary MGB Biopharma Ltd (MGB) is a clinical stage biopharmaceutical company which develops anti-infective medicine of minor groove binder (MGBs) compounds. The company focuses on the development of new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria. It offers its lead drug candidate, MGB-BP-3 in the field of antibacterial resistance. The company provides programmes which include Oral, gram-positive IV, topical, gram negative, anti-fungal, anti-viral, anti-parasitic. It provides anti-infective platform solutions to deliver drugs against multi-resistant Gram-negative pathogens, viruses, fungi and parasitic diseases. The company seeks to work in partnership with research institutes and pharmaceutical companies in the antibiotics ......

Kindred Healthcare Inc (KND) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kindred Healthcare Inc (Kindred Healthcare) is a healthcare services provider with focus on post-acute care services. The company through its subsidiaries offers home health, hospice and community care services to patients in homes, nursing centers, and other residential settings. It operates transitional care (TC) hospitals, inpatient rehabilitation hospitals (IRFs), community care business, assisted living facilities, nursing centers, a contract rehabilitation services business and a home health and hospice business in the US. It offers community care services such as personal care (bathing and grooming), meal preparation, companionship, light housekeeping, shopping, respite care, and transportation. Kindred Healthcare is headquartered in Louisville, Kentucky, the US. Kindr......